JZJian Zhuang

Jian Zhuang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jian Zhuang has a total of 127 co-authors. Here are the top co-authors by number of shared publications:

  • Hailong Qiu

    Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

    12 shared publications
  • Shusheng Wen

    Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China

    10 shared publications
  • Tianyu Chen

    Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

    10 shared publications
  • Jianzheng Cen

    Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China

    8 shared publications
  • Jimei Chen

    Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China

    8 shared publications
  • Xiaobing Liu

    Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China

    8 shared publications

Latest Publications

  • Open Access

    Population-specific association and risk discrimination utility of the cardiometabolic index for prevalent hypertension–diabetes comorbidity: insights from CHARLS and NHANES

    by Ting You, Jia Xu, Jukun Liu, Linhui Jiang, Zhihao Deng, Yinglan Liu, Hailong Qiu, Jia Zhou, Caixia Sun, Tianyu Chen, et al.

  • Open Access

    Continuous suture technique for aortic valve replacement in patients with small aortic annulus

    by Shenghua Liang, Kan Zhou, Peizeng Liu, Jue Yang, Jian Zhuang, Zerui Chen

    Original Article Continuous suture technique for aortic valve replacement in patients with small aortic annulus Shenghua Liang, Kan Zhou, Peizeng Liu, Jue Yang, Jian Zhuang, Zerui Chen


  • Congenitally corrected transposition of the great arteries: outcomes after single ventricle palliation

    by Tianyu Chen, Zewen Chen, Miao Tian, Hailong Qiu, Jianzheng Cen, Shusheng Wen, Jimei Chen, Xiaobing Liu, Jian Zhuang

    Background Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital cardiac anomaly. As a viable alternative for complex anatomical variants, the outcomes of single-ventricle palliation (SVP) in ccTGA patients remain poorly defined. Methods We conducted a single-center retrospective analysis of ccTGA patients who underwent SVP between January 2004 and December 2020. Results A total of 73 patients were included. Patients with ccTGA undergoing SVP demonstrated excellent early and mid-term outcomes, with no observed mortality and freedom from MAEs of 96.0%, 93.6%, and 78.0% at 5, 10, and 15 years postoperatively, respectively. Conclusions SVP can achieve excellent early and mid-term outcomes in carefully selected ccTGA patients. When complex biventricular repair is not feasible, SVP represents a safe and effective alternative. Impact Single-ventricle palliation can achieve excellent outcomes in selected congenitally corrected transposition of the great arteries. When complex biventricular repair is not feasible, SVP represents a safe and effective alternative.


  • Open Access

    20 years of experience with the Fontan procedure: Risk factors for adverse outcomes

    by Tianyu Chen, Linjiang Han, Hailong Qiu, Zewen Chen, Jianzheng Cen, Shusheng Wen, Jimei Chen, Xiaobing Liu, Jian Zhuang


  • Fontan completion in adulthood in patients with a functional single ventricle

    by Tianyu Chen, Jianzheng Cen, Shusheng Wen, Jimei Chen, Xiaobing Liu, Jian Zhuang

  • Open Access

    Gut microbiota community and metabolic profiles in direct total cavopulmonary connection and Fontan circulation: a cross-sectional study in the single center

    by Kaiyu Wang, Linjiang Han, Jianrui Ma, Yushen Fang, Yinru He, Xiaobing Liu, Shusheng Wen, Jian Zhuang, Haiyun Yuan

    Background: This study aimed to evaluate the impact of the direct total cavopulmonary connection (dTCPC) procedure on the gut microbiome and metabolome. It also sought to elucidate the features of the gut microbiota community and metabolic profiles in Fontan circulation.Methods: We randomly recruited 45 participants above 14 years old undergoing Fontan procedure by typical extracardiac conduit (TCPC group, n = 15), direct total cavopulmonary connection (dTCPC group, n = 16) procedure and healthy control (control group, n = 14) in our institution between May 2023 and October 2023. 16S rRNA amplicon sequencing and untargeted metabolites measurement were performed on their fecal sample.Results: The four alpha diversity indexes showed no statistical significance between the dTCPC and TCPC groups (p > 0.05). Orthogonal partial least squares discriminant analysis (OPLS-DA) followed by permutation testing indicated an overfitting effect in the model between the dTCPC and TCPC groups. We observed significant differences in the Chao1 index (p = 0.0236), the ACE index (p = 0.0236), and the unweighted beta diversity (p = 0.0099) between the Fontan group and healthy control group. Strains of Fusobacterium were significantly overrepresented in the Fontan group [with linear discriminant analysis (LDA) scores exceeding (log10) >3]. Functional enrichment analysis revealed a significant overrepresentation of several metabolic pathways. These pathways predominantly included those related to amino acid metabolism, such as histidine metabolism, glycine, serine, and threonine metabolism, and cysteine and methionine metabolism. Additionally, the biosynthesis of unsaturated fatty acids was also notably enriched.Conclusion: The dTCPC procedure demonstrated similar gut microbiota composition and metabolic profiles to the traditional ECC procedure in Fontan patients. Notably, the increased abundance of Fusobacterium, reduced microbial biodiversity, and altered metabolic profiles of amino acids and unsaturated fatty acids in the alimentary canal may serve as distinctive characteristics of patients who have undergone Fontan circulation. These findings provide valuable insights into the long-term physiological consequences of Fontan procedure and may inform future clinical management strategies.


  • Ascending aortic length predicts adverse outcomes in type A intramural haematoma

    by Zerui Chen, Jinlin Wu, Jie Liu, Jiayu Song, Hailong Qiu, Jian Zhuang

    OBJECTIVES: Ascending aortic length has recently been recognized as a novel predictor of adverse events in aortic diseases, but its prognostic value in type A intramural haematoma is unknown. We aimed to evaluate the association between ascending aortic length and outcomes in patients with type A intramural haematoma initially managed medically. METHODS: We retrospectively analysed patients with acute type A intramural haematoma. Ascending aortic length was measured by computed tomography. The primary outcome was aortic progression, defined as aortic intervention or aortic-related death. RESULTS: A total of 98 patients were enrolled. During a median follow-up of 2.6 years, aortic progression occurred in 27 patients (27.6%), i.e. 9 events per 100 patient-years. Patients with ascending aortic length ≥11 cm had significantly higher rates of aortic progression [54.2% (20.9 events per 100 patient-years) vs 18.9% (6.1 events per 100 patient-years), P = 0.001], surgical intervention (45.8% vs 12.2%, P = 0.001) and presence of ulcer-like projection (25.0% vs 2.7%, P = 0.002) compared to those with ascending aortic length <11 cm. Kaplan–Meier analysis demonstrated lower progression-free survival in the ascending aortic length ≥11 cm group (P = 0.0021). Ascending aortic length had a sensitivity of 61.9% and specificity of 77.8% for predicting aortic progression, with an area under the curve of 0.756 (95% confidence interval 0.649–0.862). CONCLUSIONS: Ascending aortic elongation may identify a high-risk subgroup of acute type A intramural haematoma patients initially managed medically who could potentially benefit from early surgery. Ascending aortic length should be considered in the risk stratification and management of these patients.


  • Open Access

    Myogenin Regulates DUSP13 to Inhibit Apoptosis Induced by Reactive Oxygen Species

    by Jing Luo, Qiang Gao, Hailong Qiu, Shuai Zhang, Wanwan Zou, Ping Wang, Lishi Zhou, Lingling Liu, Feng Xu, Xiaohua Li, et al.

    Background: Myogenin is well known as a crucial transcription factor in skeletal muscle development, yet its other biological functions remain unexplored. Previous research showed that myogenin suppresses apoptosis induced by angiotensin II in human induced pluripotent stem cell-derived cardiomyocytes, and offered a new perspective on myogenin’s role in cardioprotection. However, the detailed mechanism of this cardioprotection, especially under oxidative stress, is still unclear. Methods: In this study, hydrogen peroxide (H2O2) was used to generate reactive oxygen species in myogenin-overexpressing cardiomyocytes. The apoptosis was examined by flow cytometry. Transcriptome sequencing (RNA-seq) was performed to identify genes regulated by myogenin. Western blotting was used to detect the protein level of DUSP13 and the phosphorylation level of p38 mitogen-activated protein kinase (MAPK). The dual-luciferase reporter assay and ChIP assay were used to confirm the binding of myogenin to the promoter region of DUSP13. DUSP13 overexpression and knockdown assays were performed to study its anti-apoptotic role. Results: Flow cytometry analysis of apoptosis showed that overexpressing myogenin for 24 and 48 hours decreased the apoptotic ratio by 47.9% and 63.5%, respectively, compared with untreated controls. Transcriptome sequencing performed on cardiomyocytes that expressed myogenin for different amounts of time (6, 12, 24, and 48 hours) identified DUSP13 as being up-regulated by myogenin. Western blotting showed that overexpression of myogenin increased the expression of DUSP13 and decreased the phosphorylation level of p38 MAPK. A dual-luciferase reporter assay proved that myogenin bound directly to the promoter region of DUSP13 and led to strong relative luciferase activity. Direct expression of DUSP13A and DUSP13B significantly reduced the rates of apoptosis and necrosis in cells treated with H2O2. Knockdown of DUSP13B significantly increased the rate of apoptosis in cells treated with H2O2. Conclusions: The present findings suggest that myogenin might attenuate apoptosis induced by reactive oxygen species by up-regulating DUSP13 and inactivating the p38 MAPK pathway.